| Serum neurofilament light chain for individual prognostication of disease activity in people with multiple sclerosis: a retrospective modelling and validation study P Benkert, S Meier, S Schaedelin, A Manouchehrinia, Ö Yaldizli, ... The Lancet Neurology 21 (3), 246-257, 2022 | 289 | 2022 |
| Subcutaneous immunoglobulin for maintenance treatment in chronic inflammatory demyelinating polyneuropathy (PATH): a randomised, double-blind, placebo-controlled, phase 3 trial IN van Schaik, V Bril, N van Geloven, HP Hartung, RA Lewis, G Sobue, ... The Lancet Neurology 17 (1), 35-46, 2018 | 263 | 2018 |
| Gut microbiota–specific IgA+ B cells traffic to the CNS in active multiple sclerosis AK Pröbstel, X Zhou, R Baumann, S Wischnewski, M Kutza, OL Rojas, ... Science immunology 5 (53), eabc7191, 2020 | 157 | 2020 |
| Association of brain atrophy with disease progression independent of relapse activity in patients with relapsing multiple sclerosis A Cagol, S Schaedelin, M Barakovic, P Benkert, RA Todea, ... JAMA neurology 79 (7), 682-692, 2022 | 68 | 2022 |
| Neurofilament levels are associated with blood–brain barrier integrity, lymphocyte extravasation, and risk factors following the first demyelinating event in multiple sclerosis T Uher, M McComb, S Galkin, B Srpova, J Oechtering, C Barro, M Tyblova, ... Multiple Sclerosis Journal 27 (2), 220-231, 2021 | 67 | 2021 |
| Serum glial fibrillary acidic protein compared with neurofilament light chain as a biomarker for disease progression in multiple sclerosis S Meier, EAJ Willemse, S Schaedelin, J Oechtering, J Lorscheider, ... JAMA neurology 80 (3), 287-297, 2023 | 58 | 2023 |
| Intrathecal IgM production is a strong risk factor for early conversion to multiple sclerosis C Pfuhl, U Grittner, RM Gieß, M Scheel, JR Behrens, L Rasche, FC Pache, ... Neurology 93 (15), e1439-e1451, 2019 | 52 | 2019 |
| Severe Neuro-COVID is associated with peripheral immune signatures, autoimmunity and neurodegeneration: a prospective cross-sectional study MM Etter, TA Martins, L Kulsvehagen, E Pössnecker, W Duchemin, ... Nature communications 13 (1), 6777, 2022 | 51 | 2022 |
| Serum GFAP and NfL as disease severity and prognostic biomarkers in patients with aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder P Schindler, U Grittner, J Oechtering, D Leppert, N Siebert, AS Duchow, ... Journal of Neuroinflammation 18 (1), 105, 2021 | 51 | 2021 |
| Vitamin D3 supplementation and neurofilament light chain in multiple sclerosis J Smolders, M Mimpen, J Oechtering, J Damoiseaux, ... Acta Neurologica Scandinavica 141 (1), 77-80, 2020 | 32 | 2020 |
| Association of serum Epstein–Barr nuclear antigen-1 antibodies and intrathecal immunoglobulin synthesis in early multiple sclerosis C Pfuhl, J Oechtering, L Rasche, RM Gieß, JR Behrens, K Wakonig, ... Journal of neuroimmunology 285, 156-160, 2015 | 32 | 2015 |
| Monitoring of radiologic disease activity by serum neurofilaments in MS T Uher, S Schaedelin, B Srpova, C Barro, N Bergsland, M Dwyer, ... Neurology: Neuroimmunology & Neuroinflammation 7 (4), e714, 2020 | 26 | 2020 |
| Magnetic microparticles for endovascular aneurysm treatment: in vitro and in vivo experimental results J Oechtering, PJ Kirkpatrick, AGK Ludolph, FJ Hans, B Sellhaus, ... Neurosurgery 68 (5), 1388-1398, 2011 | 24 | 2011 |
| Intrathecal immunoglobulin M synthesis is an independent biomarker for higher disease activity and severity in multiple sclerosis J Oechtering, S Schaedelin, P Benkert, S Müller, L Achtnichts, J Vehoff, ... Annals of neurology 90 (3), 477-489, 2021 | 22 | 2021 |
| Efficacy and safety of IVIG in CIDP: Combined data of the PRIMA and PATH studies ISJ Merkies, IN van Schaik, JM Léger, V Bril, N van Geloven, HP Hartung, ... Journal of the peripheral nervous system 24 (1), 48-55, 2019 | 22 | 2019 |
| Integrative biochemical, proteomics and metabolomics cerebrospinal fluid biomarkers predict clinical conversion to multiple sclerosis F Probert, T Yeo, Y Zhou, M Sealey, S Arora, J Palace, TDW Claridge, ... Brain Communications 3 (2), fcab084, 2021 | 18 | 2021 |
| The weak association between neurofilament levels at multiple sclerosis onset and cognitive performance after 9 years L Friedova, J Motyl, B Srpova, J Oechtering, C Barro, K Vodehnalova, ... Multiple sclerosis and related disorders 46, 102534, 2020 | 18 | 2020 |
| Placebo effect in chronic inflammatory demyelinating polyneuropathy: The PATH study and a systematic review RA Lewis, DR Cornblath, HP Hartung, G Sobue, JP Lawo, O Mielke, ... Journal of the peripheral nervous system 25 (3), 230-237, 2020 | 18 | 2020 |
| Acute hydrocephalus due to impaired CSF resorption in Toscana virus meningoencephalitis J Oechtering, GC Petzold Neurology 79 (8), 829-831, 2012 | 16 | 2012 |
| Restabilization treatment after intravenous immunoglobulin withdrawal in chronic inflammatory demyelinating polyneuropathy: results from the pre‐randomization phase of the … O Mielke, V Bril, DR Cornblath, JP Lawo, N van Geloven, HP Hartung, ... Journal of the peripheral nervous system 24 (1), 72-79, 2019 | 15 | 2019 |
